ArticleOncotarget2017
ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells.
Dun Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncotarget2017
Dun Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.